drugset / Trial / NCT00945672
A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease
RandomizedTriple-blindTreatment
Summary
The purpose of this study is to determine whether multiple dose administration is safe and well tolerated in patients with mild to moderate Alzheimer's Disease.
Timeline
- Start
- 2009-08-06
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ponezumab | Monoclonal antibody | 7.5 mg/kg | — |
| Subject | Ponezumab | Monoclonal antibody | 10 mg/kg | — |